Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Brian J. Mog, Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang, Jacqueline Douglass, Emily Han Chung Hsiue, Stephanie Glavaris, Katharine M. Wright, Maximilian F. Konig, Suman Paul, Nicolas Wyhs, Jiaxin Ge, Michelle S. Miller, P. Aitana Azurmendi, Evangeline Watson, Drew M. Pardoll, Sandra B. Gabelli, Chetan BettegowdaNickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Shibin ZhouShow 4 othersShow less